Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients

被引:82
作者
Retsky, M [1 ]
Bonadonna, G
Demicheli, R
Folkman, J
Hrushesky, W
Valagussa, P
机构
[1] Childrens Hosp, Dept Surg Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Milan Natl Canc Inst, Dept Med Oncol, Milan, Italy
[4] Univ S Carolina, Sch Med, Columbia, SC USA
[5] Dorn Vet Affairs Med Ctr, Columbia, SC USA
关键词
adjuvant chemotherapy; angiogenesis; breast cancer dormancy; mammography controversy; surgery;
D O I
10.1186/bcr804
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We suggest that surgical extirpation of primary breast cancer among other effects accelerates relapse for some premenopausal node-positive patients. These accelerated relapses occur within 10 months of surgery for untreated patients. The mechanism proposed is a stimulation of angiogenesis for distant dormant micrometastases. This has been suggested as one of the mechanisms to explain the mammography paradox for women aged 40-49 years. We could imagine that it also plays a role in adjuvant chemotherapy effectiveness since, perhaps not coincidentally, this is most beneficial for premenopausal node-positive patients. Hypothesis We speculate that there is a burst of angiogenesis of distant dormant micrometastases after surgery in approximately 20% of premenopausal node-positive patients. We also speculate that this synchronizes them into a temporal highly chemosensitive state and is the underlying reason why adjuvant chemotherapy works particularly well for that patient category. Furthermore, this may explain why cancer in younger patients is more often 'aggressive'. Testing the hypothesis Stimulation of dormant micrometastases by primary tumor removal is known to occur in animal models. However, we need to determine whether it happens in breast cancer. Transient circulating levels of angioactive molecules and serial high-resolution imaging studies of focal angiogenesis might help. Implications Short-course cytotoxic chemotherapy after surgery has probably reached its zenith, and other strategies, perhaps antiangiogenic methods, are needed to successfully treat more patients. In addition, the hypothesis predicts that early detection, which is designed to find more patients without involved lymph nodes, may not be a synergistic strategy with adjuvant chemotherapy, which works best with positive lymph node patients.
引用
收藏
页码:R372 / R374
页数:3
相关论文
共 13 条
[1]  
Abe O, 1998, LANCET, V352, P930
[2]   Mammography screening: Are women really giving informed consent? [J].
Baines, CJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (20) :1508-1511
[3]   Does breast cancer exist in a state of chaos? [J].
Baum, M ;
Chaplain, MAJ ;
Anderson, ARA ;
Douek, M ;
Vaidya, JS .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) :886-891
[4]   CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP [J].
BONADONNA, G ;
VALAGUSSA, P ;
MOLITERNI, A ;
ZAMBETTI, M ;
BRAMBILLA, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :901-906
[5]   Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3):: Relevance to screening [J].
Demicheli, R ;
Bonadonna, G ;
Hrushesky, WJM ;
Retsky, MW ;
Valagussa, P .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :102-107
[6]   Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures' [J].
Demicheli, R ;
Miceli, R ;
Brambilla, C ;
Ferrari, L ;
Moliterni, A ;
Zambetti, M ;
Valagussa, P ;
Bonadonna, G .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 53 (03) :209-215
[7]   The effect of surgical wounding on tumour development [J].
Hofer, SOP ;
Molema, G ;
Hermens, RAEC ;
Wanebo, HJ ;
Reichner, JS ;
Hoekstra, HJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (03) :231-243
[8]   The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up - A randomized screening trial of mammography in women age 40 to 49 years [J].
Miller, AB ;
To, T ;
Baines, CJ ;
Wall, C .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (05) :305-312
[9]  
Naumov GN, 2002, CANCER RES, V62, P2162
[10]  
*NIH CONS C, 1985, JAMA-J AM MED ASSOC, V254, P3461